NAVB
Price:
$0.000099999997
Market Cap:
$100.00
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It...[Read more]
Industry
Biotechnology
IPO Date
1992-11-10
Stock Exchange
OTC
Ticker
NAVB
According to Navidea Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 355.34%. This represents a change of -427.68% compared to the average of -108.44% of the last 4 quarters.
The mean historical ROE of Navidea Biopharmaceuticals, Inc. over the last ten years is 1.20%. The current 355.34% ROE has changed -70.49% with respect to the historical average. Over the past ten years (40 quarters), NAVB's ROE was at its highest in in the December 2021 quarter at 3.43%. The ROE was at its lowest in in the September 2020 quarter at -1706.73%.
Average
1.20%
Median
149.89%
Minimum
-925.67%
Maximum
11.01%
Discovering the peaks and valleys of Navidea Biopharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.04%
Maximum Annual ROE = 11.01%
Minimum Annual Increase = -1450.88%
Minimum Annual ROE = -925.67%
| Year | ROE | Change |
|---|---|---|
| 2022 | 179.91% | -98.37% |
| 2021 | 11.01% | -1450.88% |
| 2020 | -814.96% | -220.05% |
| 2019 | 678.88% | -173.34% |
| 2018 | -925.67% | -240.55% |
| 2017 | 658.60% | 3.04% |
| 2016 | 21.00% | -58.62% |
| 2015 | 50.76% | -57.66% |
| 2014 | 119.87% | -88.74% |
| 2013 | 1.06% | -48.67% |
The current ROE of Navidea Biopharmaceuticals, Inc. (NAVB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.46%
5-year avg
2.03%
10-year avg
1.20%
Navidea Biopharmaceuticals, Inc.’s ROE is less than Generex Biotechnology Corporation (216.76%), less than WPD Pharmaceuticals Inc. (15.48%), less than Nanomix Corporation (128.37%), less than NeonMind Biosciences Inc. (366.65%), less than Gelesis Holdings, Inc. (31.43%), less than MobileSmith, Inc. (225.88%), greater than Goodbody Health Limited (-34.66%), less than Gene Biotherapeutics, Inc. (12.69%), greater than MagForce AG (-33.92%), less than Acorda Therapeutics, Inc. (786.07%),
| Company | ROE | Market cap |
|---|---|---|
| 216.76% | $0 | |
| 15.48% | $140.00 | |
| 128.37% | $9.80K | |
| 366.65% | $8.54K | |
| 31.43% | $7.33K | |
| 225.88% | $8.52K | |
| -34.66% | $365.00 | |
| 12.69% | $6.49K | |
| -33.92% | $11.97K | |
| 786.07% | $12.42K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Navidea Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Navidea Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Navidea Biopharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Navidea Biopharmaceuticals, Inc. (NAVB)?
What is the highest ROE for Navidea Biopharmaceuticals, Inc. (NAVB)?
What is the 3-year average ROE for Navidea Biopharmaceuticals, Inc. (NAVB)?
What is the 5-year average ROE for Navidea Biopharmaceuticals, Inc. (NAVB)?
How does the current ROE for Navidea Biopharmaceuticals, Inc. (NAVB) compare to its historical average?